Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15.4M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
4.57M
-
Shares change
-
+209K
-
Total reported value, excl. options
-
$48.8M
-
Value change
-
+$2.28M
-
Number of buys
-
14
-
Number of sells
-
-21
-
Price
-
$10.67
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q2 2016
46 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q2 2016.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.57M shares
of 15.4M outstanding shares and own 29.57% of the company stock.
Largest 10 shareholders include Karpus Management, Inc. (997K shares), First Allied Advisory Services, Inc. (592K shares), MORGAN STANLEY (543K shares), WELLS FARGO & COMPANY/MN (446K shares), RAYMOND JAMES & ASSOCIATES (414K shares), Thomas J. Herzfeld Advisors, Inc. (280K shares), ROYAL BANK OF CANADA (237K shares), GAMCO INVESTORS, INC. ET AL (225K shares), MSI Financial Services Inc (96.4K shares), and CITIGROUP INC (96.1K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.